Analyze Diet
Scientific reports2017; 7(1); 7431; doi: 10.1038/s41598-017-06939-w

Circulating microRNA profiles of Hendra virus infection in horses.

Abstract: Hendra virus (HeV) is an emerging zoonotic pathogen harbored by Australian mainland flying foxes. HeV infection can cause lethal disease in humans and horses, and to date all cases of human HeV disease have resulted from contact with infected horses. Currently, diagnosis of acute HeV infections in horses relies on the productive phase of infection when virus shedding may occur. An assay that identifies infected horses during the preclinical phase of infection would reduce the risk of zoonotic viral transmission during management of HeV outbreaks. Having previously shown that the host microRNA (miR)-146a is upregulated in the blood of HeV-infected horses days prior to the detection of viremia, we have profiled miRNAs at the transcriptome-wide level to comprehensively assess differences between infected and uninfected horses. Next-generation sequencing and the miRDeep2 algorithm identified 742 mature miRNA transcripts corresponding to 593 miRNAs in whole blood of six horses (three HeV-infected, three uninfected). Thirty seven miRNAs were differentially expressed in infected horses, two of which were validated by qRT-PCR. This study describes a methodology for the transcriptome-wide profiling of miRNAs in whole blood and supports the notion that measuring host miRNA expression levels may aid infectious disease diagnosis in the future.
Publication Date: 2017-08-07 PubMed ID: 28785041PubMed Central: PMC5547158DOI: 10.1038/s41598-017-06939-wGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article focuses on using circulating microRNA profiles to identify Hendra virus infection in horses before the active, virus shedding stage, with the aim of reducing the risk of the virus spreading to humans.

Introduction and Background

  • The paper revolves around the Hendra virus (HeV), which is a zoonotic pathogen found primarily in flying foxes on the Australian mainland and can cause lethal disease in both humans and horses. Importantly, every known human case of HeV has resulted from contact with an infected horse.
  • In its current form, diagnosing HeV infection in horses relies on identifying the virus during its productive phase when the virus is being shed. This can pose a significant risk for human handlers and carers of horses.

Objective and Methodology

  • This research aimed to develop a diagnostic tool that could identify infected horses during the preclinical phase of the infection, potentially reducing the risk of viral transmission to humans.
  • The scientists had earlier found that the host microRNA (miR)-146a is elevated in the blood of HeV-infected horses days before viremia (the presence of viruses in the blood) can be detected.
  • Using an expanded approach, the study used next-generation sequencing and the miRDeep2 algorithm to profile miRNAs at the transcriptome-wide level and to assess differences between infected and uninfected horses more comprehensively.

Results and Insights

  • The team identified 742 mature miRNA transcripts corresponding to 593 miRNAs in the whole blood of six horses (three HeV-infected, three uninfected).
  • They found that 37 miRNAs were differentially expressed in infected horses, with two of these findings validated by qRT-PCR (a common laboratory technique used to measure RNA expression).

Conclusion and Implications

  • The study describes a methodology for profiling miRNAs on a full transcriptome scale in whole blood, a significant step forward in the field of diagnostics.
  • The findings of this research suggest that monitoring host miRNA expression levels can potentially be a valuable tool to aid in infectious disease diagnosis in the future, specifically for zoonotic diseases like Hendra virus.

Cite This Article

APA
Cowled C, Foo CH, Deffrasnes C, Rootes CL, Williams DT, Middleton D, Wang LF, Bean AGD, Stewart CR. (2017). Circulating microRNA profiles of Hendra virus infection in horses. Sci Rep, 7(1), 7431. https://doi.org/10.1038/s41598-017-06939-w

Publication

ISSN: 2045-2322
NlmUniqueID: 101563288
Country: England
Language: English
Volume: 7
Issue: 1
Pages: 7431

Researcher Affiliations

Cowled, Christopher
  • CSIRO Australian Animal Health Laboratory, Geelong, Victoria, Australia. chris.cowled@csiro.au.
Foo, Chwan-Hong
  • CSIRO Australian Animal Health Laboratory, Geelong, Victoria, Australia.
Deffrasnes, Celine
  • CSIRO Australian Animal Health Laboratory, Geelong, Victoria, Australia.
Rootes, Christina L
  • CSIRO Australian Animal Health Laboratory, Geelong, Victoria, Australia.
Williams, David T
  • CSIRO Australian Animal Health Laboratory, Geelong, Victoria, Australia.
Middleton, Deborah
  • CSIRO Australian Animal Health Laboratory, Geelong, Victoria, Australia.
Wang, Lin-Fa
  • Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.
Bean, Andrew G D
  • CSIRO Australian Animal Health Laboratory, Geelong, Victoria, Australia.
Stewart, Cameron R
  • CSIRO Australian Animal Health Laboratory, Geelong, Victoria, Australia.

MeSH Terms

  • Animals
  • Australia
  • Circulating MicroRNA / blood
  • Circulating MicroRNA / genetics
  • Early Diagnosis
  • Gene Expression Profiling / veterinary
  • Gene Expression Regulation
  • Hendra Virus / pathogenicity
  • Henipavirus Infections / blood
  • Henipavirus Infections / diagnosis
  • Henipavirus Infections / genetics
  • Henipavirus Infections / veterinary
  • High-Throughput Nucleotide Sequencing / veterinary
  • Horse Diseases / blood
  • Horse Diseases / diagnosis
  • Horse Diseases / genetics
  • Horses / blood
  • Horses / genetics
  • Sequence Analysis, RNA / veterinary

Conflict of Interest Statement

The authors declare that they have no competing interests.

References

This article includes 38 references
  1. Halpin K, Young PL, Field HE, Mackenzie JS. Isolation of Hendra virus from pteropid bats: a natural reservoir of Hendra virus.. J Gen Virol 2000;81:1927–1932.
    doi: 10.1099/0022-1317-81-8-1927pubmed: 10900029google scholar: lookup
  2. Murray K. A morbillivirus that caused fatal disease in horses and humans.. Science 1995;268:94–97.
    doi: 10.1126/science.7701348pubmed: 7701348google scholar: lookup
  3. Middleton D. Hendra virus vaccine, a one health approach to protecting horse, human, and environmental health.. Emerg Infect Dis 2014;20:372–379.
    doi: 10.3201/eid2003.131159pmc: PMC3944873pubmed: 24572697google scholar: lookup
  4. Marsh GA. Experimental infection of horses with Hendra virus/Australia/horse/2008/Redlands.. Emerg Infect Dis 2011;17:2232–2238.
    doi: 10.3201/eid1712.111162pmc: PMC3311212pubmed: 22172152google scholar: lookup
  5. Daniels P, Ksiazek T, Eaton BT. Laboratory diagnosis of Nipah and Hendra virus infections.. Microbes Infect 2001;3:289–295.
    doi: 10.1016/S1286-4579(01)01382-Xpubmed: 11334746google scholar: lookup
  6. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14.. Cell 1993;75:843–854.
    doi: 10.1016/0092-8674(93)90529-Ypubmed: 8252621google scholar: lookup
  7. Lee RC, Ambros V. An extensive class of small RNAs in Caenorhabditis elegans.. Science 2001;294:862–864.
    doi: 10.1126/science.1065329pubmed: 11679672google scholar: lookup
  8. Lau NC, Lim LP, Weinstein EG, Bartel DP. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans.. Science 2001;294:858–862.
    doi: 10.1126/science.1065062pubmed: 11679671google scholar: lookup
  9. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs.. Science 2001;294:853–858.
    doi: 10.1126/science.1064921pubmed: 11679670google scholar: lookup
  10. Gantier MP. New perspectives in MicroRNA regulation of innate immunity.. J Interferon Cytokine Res 2010;30:283–289.
    doi: 10.1089/jir.2010.0037pubmed: 20477549google scholar: lookup
  11. Meister G, Tuschl T. Mechanisms of gene silencing by double-stranded RNA.. Nature 2004;431:343–349.
    doi: 10.1038/nature02873pubmed: 15372041google scholar: lookup
  12. Tomari Y, Zamore PD. Perspective: machines for RNAi.. Genes Dev 2005;19:517–529.
    doi: 10.1101/gad.1284105pubmed: 15741316google scholar: lookup
  13. Chen X. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases.. Cell Res 2008;18:997–1006.
    doi: 10.1038/cr.2008.282pubmed: 18766170google scholar: lookup
  14. Li LM. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma.. Cancer Res 2010;70:9798–9807.
    doi: 10.1158/0008-5472.CAN-10-1001pubmed: 21098710google scholar: lookup
  15. Gilad S. Serum microRNAs are promising novel biomarkers.. PLoS One 2008;3:e3148.
  16. Stewart CR. Promotion of Hendra virus replication by microRNA 146a.. J Virol 87, 3782–3791.
    pmc: PMC3624204pubmed: 23345523doi: 10.1128/jvi.01342-12google scholar: lookup
  17. Boldin MP. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice.. J Exp Med 2011;208:1189–1201.
    doi: 10.1084/jem.20101823pmc: PMC3173243pubmed: 21555486google scholar: lookup
  18. Hou J. MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2.. J Immunol 2009;183:2150–2158.
    doi: 10.4049/jimmunol.0900707pubmed: 19596990google scholar: lookup
  19. Cameron JE. Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways.. J Virol 2008;82:1946–1958.
    doi: 10.1128/JVI.02136-07pmc: PMC2258704pubmed: 18057241google scholar: lookup
  20. Cowled C. Characterisation of novel microRNAs in the Black flying fox (Pteropus alecto) by deep sequencing.. BMC Genomics 15, 682.
    pmc: PMC4156645pubmed: 25128405doi: 10.1186/1471-2164-15-682google scholar: lookup
  21. Friedlander MR, Mackowiak SD, Li N, Chen W, Rajewsky N. miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades.. Nucleic Acids Res 2012;40:37–52.
    doi: 10.1093/nar/gkr688pmc: PMC3245920pubmed: 21911355google scholar: lookup
  22. Anders S, Huber W. Differential expression analysis for sequence count data.. Genome Biol 2010;11:R106.
    doi: 10.1186/gb-2010-11-10-r106pmc: PMC3218662pubmed: 20979621google scholar: lookup
  23. Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data.. Bioinformatics 2010;26:139–140.
  24. Peltier HJ, Latham GJ. Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues.. RNA 2008;14:844–852.
    doi: 10.1261/rna.939908pmc: PMC2327352pubmed: 18375788google scholar: lookup
  25. Munshi SU, Panda H, Holla P, Rewari BB, Jameel S. MicroRNA-150 is a potential biomarker of HIV/AIDS disease progression and therapy.. PLoS One 2014;9:e95920.
  26. Asahchop EL. Plasma microRNA profiling predicts HIV-associated neurocognitive disorder.. AIDS 2016;30:2021–2031.
    doi: 10.1097/QAD.0000000000001160pubmed: 27191977google scholar: lookup
  27. Akamatsu S. Differences in serum microRNA profiles in hepatitis B and C virus infection.. J Infect 2015;70:273–287.
    doi: 10.1016/j.jinf.2014.10.017pubmed: 25452043google scholar: lookup
  28. Han MG. Serum MicroRNA Expression Profiling in Mice Infected with Rabies Virus.. Osong Public Health Res Perspect 2011;2:186–191.
    doi: 10.1016/j.phrp.2011.11.043pmc: PMC3767082pubmed: 24159471google scholar: lookup
  29. Duy J. Circulating microRNA profiles of Ebola virus infection.. Sci Rep 2016;6:24496.
    doi: 10.1038/srep24496pmc: PMC4838880pubmed: 27098369google scholar: lookup
  30. Zhou M. In silico detection and characteristics of novel microRNA genes in the Equus caballus genome using an integrated ab initio and comparative genomic approach.. Genomics 2009;94:125–131.
    doi: 10.1016/j.ygeno.2009.04.006pubmed: 19406225google scholar: lookup
  31. Lee S. Expression of microRNAs in Horse Plasma and Their Characteristic Nucleotide Composition.. PLoS One 2016;11:e0146374.
  32. Pritchard CC. Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies.. Cancer Prev Res (Phila) 2012;5:492–497.
  33. Blondal T. Assessing sample and miRNA profile quality in serum and plasma or other biofluids.. Methods 2013;59:S1–6.
    doi: 10.1016/j.ymeth.2012.09.015pubmed: 23036329google scholar: lookup
  34. Schwarzenbach H, da Silva AM, Calin G, Pantel K. Data Normalization Strategies for MicroRNA Quantification.. Clin Chem 2015;61:1333–1342.
  35. Foo CH. Dual microRNA Screens Reveal That the Immune-Responsive miR-181 Promotes Henipavirus Entry and Cell-Cell Fusion.. PLoS Pathog 12, e1005974.
  36. Griffiths-Jones S. The microRNA Registry.. Nucleic Acids Res 2004;32:D109–111.
    doi: 10.1093/nar/gkh023pmc: PMC308757pubmed: 14681370google scholar: lookup
  37. Smith IL, Halpin K, Warrilow D, Smith GA. Development of a fluorogenic RT-PCR assay (TaqMan) for the detection of Hendra virus.. J Virol Methods 2001;98:33–40.
    doi: 10.1016/S0166-0934(01)00354-8pubmed: 11543882google scholar: lookup
  38. McNabb L. Henipavirus microsphere immuno-assays for detection of antibodies against Hendra virus.. J Virol Methods 2014;200:22–28.

Citations

This article has been cited 11 times.
  1. Cullen JN, Cieslak J, Petersen JL, Bellone RR, Finno CJ, Kalbfleisch TS, Calloe K, Capomaccio S, Cappelli K, Coleman SJ, Distl O, Durward-Akhurst SA, Giulotto E, Hamilton NA, Hill EW, Katz LM, Klaerke DA, Lindgren G, MacHugh DE, Mackowski M, MacLeod JN, Metzger J, Murphy BA, Orlando L, Raudsepp T, Silvestrelli M, Strand E, Tozaki T, Trachsel DS, Valderrama Figueroa LS, Velie BD, Wade CM, Waud B, Mickelson JR, McCue ME. Charting the equine miRNA landscape: An integrated pipeline and browser for annotating, quantifying, and visualizing expression. PLoS Genet 2025 Sep;21(9):e1011835.
    doi: 10.1371/journal.pgen.1011835pubmed: 40911641google scholar: lookup
  2. Wilson A, Farr RJ, Hine BC, Sanchez-Molano E, Rootes CL, Su J, Banos G, Stewart CR, Ingham AB. Circulating microRNAs associated with immune competence in Angus cattle. J Anim Sci 2025 Jan 4;103.
    doi: 10.1093/jas/skaf144pubmed: 40313035google scholar: lookup
  3. Farr RJ, Dahal S, Tribolet L, Bean AGD, Cowled C, Stewart CR. Profiling Host MicroRNA Responses to Henipavirus Infection. Methods Mol Biol 2023;2682:261-279.
    doi: 10.1007/978-1-0716-3283-3_19pubmed: 37610588google scholar: lookup
  4. Ostrycharz E, Hukowska-Szematowicz B. Micro-Players of Great Significance-Host microRNA Signature in Viral Infections in Humans and Animals. Int J Mol Sci 2022 Sep 11;23(18).
    doi: 10.3390/ijms231810536pubmed: 36142450google scholar: lookup
  5. Letafati A, Najafi S, Mottahedi M, Karimzadeh M, Shahini A, Garousi S, Abbasi-Kolli M, Sadri Nahand J, Tamehri Zadeh SS, Hamblin MR, Rahimian N, Taghizadieh M, Mirzaei H. MicroRNA let-7 and viral infections: focus on mechanisms of action. Cell Mol Biol Lett 2022 Feb 14;27(1):14.
    doi: 10.1186/s11658-022-00317-9pubmed: 35164678google scholar: lookup
  6. Farr RJ, Godde N, Cowled C, Sundaramoorthy V, Green D, Stewart C, Bingham J, O'Brien CM, Dearnley M. Machine Learning Identifies Cellular and Exosomal MicroRNA Signatures of Lyssavirus Infection in Human Stem Cell-Derived Neurons. Front Cell Infect Microbiol 2021;11:783140.
    doi: 10.3389/fcimb.2021.783140pubmed: 35004351google scholar: lookup
  7. Farr RJ, Rootes CL, Rowntree LC, Nguyen THO, Hensen L, Kedzierski L, Cheng AC, Kedzierska K, Au GG, Marsh GA, Vasan SS, Foo CH, Cowled C, Stewart CR. Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection. PLoS Pathog 2021 Jul;17(7):e1009759.
    doi: 10.1371/journal.ppat.1009759pubmed: 34320031google scholar: lookup
  8. Liu L, Fang C, Sun Y, Liu W. Evaluation of key miRNAs during early pregnancy in Kazakh horse using RNA sequencing. PeerJ 2021;9:e10796.
    doi: 10.7717/peerj.10796pubmed: 33665012google scholar: lookup
  9. Tribolet L, Kerr E, Cowled C, Bean AGD, Stewart CR, Dearnley M, Farr RJ. MicroRNA Biomarkers for Infectious Diseases: From Basic Research to Biosensing. Front Microbiol 2020;11:1197.
    doi: 10.3389/fmicb.2020.01197pubmed: 32582115google scholar: lookup
  10. Raza SHA, Kaster N, Khan R, Abdelnour SA, El-Hack MEA, Khafaga AF, Taha A, Ohran H, Swelum AA, Schreurs NM, Zan L. The Role of MicroRNAs in Muscle Tissue Development in Beef Cattle. Genes (Basel) 2020 Mar 11;11(3).
    doi: 10.3390/genes11030295pubmed: 32168744google scholar: lookup
  11. Carossino M, Dini P, Kalbfleisch TS, Loynachan AT, Canisso IF, Shuck KM, Timoney PJ, Cook RF, Balasuriya UBR. Downregulation of MicroRNA eca-mir-128 in Seminal Exosomes and Enhanced Expression of CXCL16 in the Stallion Reproductive Tract Are Associated with Long-Term Persistence of Equine Arteritis Virus. J Virol 2018 May 1;92(9).
    doi: 10.1128/JVI.00015-18pubmed: 29444949google scholar: lookup